Fingolimod: a guide to its use in multiple sclerosis in the EU

Author： Scott Lesley J.   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.10, 2012-10, pp. : 6-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU

By Lyseng-Williamson Katherine A.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Fingolimod: A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis

By Scott Lesley J.  

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 673-698

Adis International

Access to resources Recommend Favorite

Fingolimod for relapsing multiple sclerosis: an update

By Horga Alejandro   Castilló Joaquín   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1183-1196

Informa Healthcare

Access to resources Recommend Favorite

Fingolimod for the treatment of relapsing multiple sclerosis

By Singer Barry A  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite

Fingolimod: Multiple sclerosis relapse: case report

By  

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite